Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Clinical trials sponsored by Suzhou Suncadia Biopharmaceuticals Co., Ltd., explained in plain language.
-
New hope for lung cancer patients who failed targeted therapy: phase 3 trial launched
Disease control OngoingThis phase 3 study compares a new drug, SHR-A2009, with standard platinum-based chemotherapy in about 500 adults with advanced EGFR-mutated non-small cell lung cancer that has worsened after EGFR-targeted therapy. The main goal is to see if SHR-A2009 can delay cancer growth bette…
Phase: PHASE3 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Lung cancer combo trial pulled before starting
Disease control TerminatedThis trial was designed to test a combination of three drugs (SHR-A1921, adebrelimab, and SHR-8068) with or without chemotherapy for people with advanced non-small cell lung cancer. The goal was to see if the treatment was safe and shrank tumors. However, the study was withdrawn …
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 06, 2026 16:03 UTC
-
New drug cocktail shows promise against tough cancers
Disease control OngoingThis study tests a combination of three treatments—SHR-8068, adebrelimab, and chemotherapy—as a first-line therapy for people with advanced gastric or esophageal cancer that cannot be removed by surgery. The main goal is to see how many patients' tumors shrink significantly. Abou…
Phase: PHASE2 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 04, 2026 16:19 UTC